In this episode, Tatyana Kushner, MD, MSCE, and Stefan Zeuzem, MD, address key considerations when screening, diagnosing, and treating patients with HDV, such as:
- Barriers to HDV screening, including limitations to AASLD guideline recommendations
- Use of double reflex testing to improve HDV diagnosis
- Considerations for repeat HDV testing in patients who are HBsAg positive who previously tested negative for HDV
- Updated CDC recommendations for HBV screening for all adults using a triple panel test
- Staging advanced liver disease in patients with HDV
- Indications for HDV treatment, including patients with low ALT levels and advanced or progressive liver disease
- Treatment landscape for HDV
- Personal experiences with use of pegylated interferon for HDV treatment, including considerations for use in patients with compensated cirrhosis
- Updates on novel HDV therapies, including:
- Summary of efficacy data on bulevirtide from clinical trials
- Interpretation of results from D-LIVR, a phase III trial assessing the safety and efficacy of lonafarnib
Link to full program:
bit.ly/3yp1Lxf
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
